The global coronary stents market was valued at USD 6.68 billion in 2024 and is expected to grow to USD 10.66 billion by 2032, reflecting a compound annual growth rate (CAGR) of 6.2% during the forecast period. In 2024, North America held the leading position in the market, accounting for a 33.08% share.

The coronary stents market plays a vital role in the treatment of coronary artery disease, offering minimally invasive solutions to restore blood flow in blocked or narrowed arteries. These small, expandable devices are widely used in angioplasty procedures to support arterial walls and reduce the risk of future blockages. With the increasing prevalence of cardiovascular diseases, changing lifestyles, and advancements in interventional cardiology, demand for coronary stents continues to grow. Innovations such as drug-eluting stents, bioresorbable stents, and improved stent delivery systems are enhancing clinical outcomes and patient recovery. As healthcare systems prioritize faster, safer, and more effective treatment options, the coronary stents market is poised for continued evolution and global expansion.

Continue reading for more details:

**https://www.fortunebusinessinsights.com/industry-reports/coronary-stents-market-100065**

Market Segmentation

By Product Type

• Bare-metal stents (BMS)
• Drug-eluting stents (DES)
• Bioresorbable vascular scaffolds (BVS)

By Material

• Metallic stents
• Polymer-based stents
• Hybrid stents

By End User

• Hospitals
• Ambulatory surgical centers
• Cardiac centers
• Specialty clinics

By Mode of Delivery

• Balloon-expandable stents